Bristol-Myers Squibb Company (BMY) P/E Ratio, ROE & Key Statistics
$63.04NYSE: BMYMarket Cap $128.86B
Data as of Nov 16, 2026 (intraday, delayed) · Source: Financial Modeling Prep (methodology)
Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for Bristol-Myers Squibb Company (BMY), each with what it measures. Figures are trailing twelve months or the most recent reported period.
Valuation
Metric
Value
P/E ratioShare price divided by earnings per share.
13.54
P/B ratioShare price divided by book value per share.
5.62
P/S ratioMarket value divided by annual revenue.
2.55
PEG ratioP/E divided by the earnings growth rate.
4.88
EV / EBITDAEnterprise value against earnings before interest, tax, depreciation and amortisation.
9.24
EV / RevenueEnterprise value against annual revenue.
3.40
Earnings yieldEarnings per share as a percentage of the share price — the inverse of P/E.
5.55%
Free cash flow yieldFree cash flow as a percentage of market value.
10.11%
Price / free cash flowMarket value divided by free cash flow.
9.89
Profitability
Metric
Value
Gross marginRevenue left after the direct cost of goods sold.
70.16%
Operating marginRevenue left after operating costs.
28.14%
Net marginRevenue left after every cost, including tax and interest.
18.87%
Return on equityProfit as a percentage of shareholders’ equity.
46.75%
Return on assetsProfit as a percentage of total assets.
10.59%
Return on capital employedOperating profit against the capital the business uses.
20.07%
Financial health
Metric
Value
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.
1.26
Quick ratioThe same, excluding inventory.
1.14
Cash ratioCash alone against current liabilities.
0.44
Debt to equityTotal borrowings against shareholders’ equity.
1.93
Debt to assetsTotal borrowings against total assets.
0.52
Interest coverageHow many times operating profit covers the interest bill.
7.26
Per share and size
Metric
Value
Earnings per shareProfit attributable to each share.
$3.45
Market capitalisationShare price times shares outstanding.
$128.86B
Enterprise valueMarket value plus net debt — what it would cost to buy the business outright.
$161.42B
EmployeesReported headcount.
34,100
Dividend
Metric
Value
Dividend yieldAnnual dividend as a percentage of the share price.
4.10%
Payout ratioShare of profit paid out as dividends.
55.51%
Bristol-Myers Squibb Company (BMY) statistics — frequently asked questions
What is Bristol-Myers Squibb Company's P/E ratio?
Bristol-Myers Squibb Company (BMY) trades on a price-to-earnings ratio of 13.54.
What is Bristol-Myers Squibb Company's return on equity?
Bristol-Myers Squibb Company (BMY) reports a return on equity of 46.75%, meaning it generated that much profit for every dollar of shareholders' equity.
How much debt does Bristol-Myers Squibb Company carry?
Bristol-Myers Squibb Company (BMY) has a debt-to-equity ratio of 1.93, which compares total borrowings with shareholders' equity.
What is Bristol-Myers Squibb Company's profit margin?
Bristol-Myers Squibb Company (BMY) keeps 18.87% of revenue as net profit after every cost, including tax and interest.
P/E and ROE of other Drug Manufacturers - General stocks